Type 1 diabetes mellitus (T1DM) is the most frequent metabolic disease in children and
adolescents, with a rising incidence(1). Auto-immune mediated beta cell destruction leads to
insulin deficiency, requiring lifelong intensive management including daily frequent glucose
measurement and insulin administration to avoid long-term micro- and macro-vascular
complications (2). There are two types of insulin therapies, the conventional and the intensive
insulin therapy. While it might seem easier to manage a conventional therapy in school
because it requires fixed insulin and meal times, all recent studies showed the superiority of
intensive therapy in long term complication rates (3)(4)(5)(6)(7). Technological advances for
glucose monitoring and regulation as well as patient and family education programs have
been developed to foster self-management as well as several technological methods have
been developed. While children can perform some of the technical aspects of T1DM
management, adult surveillance is required in some situations.